IP Library Granted Patent US 10,908,145
Granted Patent B2
US 10,908,145 · App. 15/815,480 · Granted Feb 2, 2021

Device for whole blood separation

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,908,145
App. No.
15/815,480
Granted
Feb 2, 2021
Kind
B2
Abstract

Separation of the cellular components of whole blood, or other biological fluid, from plasma or serum can be achieved for assay analysis. A device for facilitating separation can include, for example, a capillary tube that accurately draws target blood volume, a pad that chemically interacts with red-blood cells, such that the red blood cells become chemically and/or physically trapped within pad material, a mechanism for plasma recovery from the pad upon diffusion or active mixing, and a dropper tip that facilitates dispensing the mixture onto a test device. The treatment of the cellular components can be performed prior to contact with a buffer solution, so release of the cellular components into the buffer solution is reduced or prevented. Additional filtration can be provided to filter any remaining cellular components in the mixture.

Claims (44)

1. A kit comprising:

a container comprising a reservoir;

a sample device comprising:

an inflow chamber for receiving a fluid sample;

a mixing chamber;

a pad between the inflow chamber and the mixing chamber, the pad comprising a processing reagent;

an outflow port adjacent to the mixing chamber; and

an interface for sealably connecting the sample device to the container such that the reservoir is in fluid communication with the mixing chamber through a channel formed between the interface and the pad, wherein the channel provides a pathway for reagents from the container to the mixing chamber.

2. The kit of claim 1 , wherein the inflow chamber comprises a capillary tube.

3. The kit of claim 2 , wherein the capillary tube has a length selected to collect a fixed volume of fluid sample.

4. The kit of claim 1 , wherein the sample device further comprises a filter between the mixing chamber and the outflow port.

5. The kit of claim 1 , further comprising a buffer solution within the reservoir.

6. The kit of claim 1 , wherein the processing reagent is a red blood cell agglomerating substance.

7. A kit comprising:

a sample device comprising:

an inflow chamber comprising a pad for receiving a liquid sample; and

a mixing chamber having an outflow port; and

a container comprising:

a reservoir configured to contain or containing reagents; and

an interface for sealably connecting the sample device to the container such that the reservoir is in fluid communication with the mixing chamber through a channel formed between the interface and the pad, wherein the channel provides a pathway for the reagents from the container to the mixing chamber.

8. The kit of claim 7 , further comprising a collection device for collecting the liquid sample.

9. The kit of claim 7 , wherein the collection device comprises a capillary tube and a bulb in fluid communication with the capillary tube.

10. The kit of claim 7 , wherein the pad comprises a processing reagent.

11. The kit of claim 10 , wherein the processing reagent is a red blood cell agglomerating substance.

12. A kit comprising:

a container comprising:

a reservoir containing or configured to contain a solution;

a mixing chamber; and

a barrier separating the reservoir from the mixing chamber;

a sample device comprising:

an inflow chamber for receiving a liquid sample;

a channel; and

a pad between the inflow chamber and the channel; and

a dispenser comprising:

an outflow port; and

an interface for sealably connecting the dispenser to the container such that the mixing chamber is in fluid communication with the outflow port through a channel formed between the interface and the pad, wherein the channel provides a pathway for reagents from the container to the outflow port, wherein the dispenser is configured to urge the sample device through the barrier when the dispenser is connected to the container.

13. The kit of claim 12 , wherein the inflow chamber comprises a capillary tube.

14. The kit of claim 12 , wherein the dispenser further comprises a filter that is between the mixing chamber and the outflow port when the dispenser is connected to the container.

15. The kit of claim 14 , wherein the filter is positioned between opposing openings of the dispenser.

16. The kit of claim 12 , wherein the container comprises at least one protrusion to secure at least a portion of the sample device within the mixing chamber.

17. The kit of claim 16 , wherein the dispenser is configured to urge the at least a portion of the sample device through the at least one protrusion when the dispenser is connected to the container.

18. The kit of claim 12 , wherein the container comprises multiple protrusions to secure at least a portion of the sample device between the multiple protrusions and within the mixing chamber.

19. The kit of claim 12 , wherein the pad comprising a processing reagent.

20. The kit of claim 19 , wherein the processing reagent is a red blood cell agglomerating substance.

Assignments (7)
SECURITY AGREEMENT Recorded Aug 22, 2025
From: CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; QUIDEL CARDIOVASCULAR INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 072526/0643 →
RELEASE (REEL 060220 / FRAME 0711) Recorded Aug 22, 2025
From: BANK OF AMERICA, N.A.
To: QUIDEL CORPORATION; BIOHELIX CORPORATION; DIAGNOSTIC HYBRIDS, INC.; QUIDEL CARDIOVASCULAR INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.
Reel/Frame 072577/0536 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2024
From: QUIDEL CORPORATION
To: ORTHO-CLINICAL DIAGNOSTICS, INC.
Reel/Frame 068657/0827 →
RELEASE OF SECURITY INTEREST Recorded May 31, 2022
From: BANK OF AMERICA, N.A.
To: QUIDEL CORPORATION
Reel/Frame 060053/0068 →
SECURITY AGREEMENT Recorded May 31, 2022
From: QUIDEL CORPORATION; BIOHELIX CORPORATION; DIAGNOSTIC HYBRIDS, INC.; QUIDEL CARDIOVASCULAR INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 060220/0711 →
SECURITY INTEREST Recorded Aug 31, 2018
From: QUIDEL CORPORATION
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 046767/0745 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 17, 2017
From: SINN BLANDY, IRENE; THIESEN, RAYNA; FALL, SCOTT ALEXANDER; REED, ROBERT; WEILLER, ROBERT
To: QUIDEL CORPORATION
Reel/Frame 044163/0195 →